QIAGEN OmicSoft and Biomedical Knowledge Base

Discoveries from public immuno-oncology studies using Omicsoft and Ingenuity Pathway Analysis

255 views
January 12, 2023
This training will focus on how QIAGEN Omicsoft Studio and Ingenuity Pathway Analysis (IPA) can be used to discover new biomarkers, validate (or study) drug targets and identify novel mechanism of action with user and/or public Immuno-Oncology studies from resources like GEO, SRA, TCGA and more.
Attendees will learn how to
• Investigate expression of a gene/biomarker/drug target across different treatments and diseases
• Derive a biomarker/gene signature from specific condition (example non-responders of a drug, a specific disease/disease subtype and more)
• Correlate expression of multiple genes and biomarkers
• Compare different experimental groups (user and/or public data) at both gene expression and pathways/regulatory networks activity levels

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...

2,010 views July 19, 2022

High-quality biomedical relationships knowledge is the cornerstone of modern...

QIAGEN OmicSoft and Biomedical Knowledge Base

Expression data analysis using QIAGEN Omicsoft Studio - Sep 28 2021

886 views October 01, 2021

In this training, users will learn how to generate downstream outputs such...

QIAGEN IPA

Discovery from public oncological data using QIAGEN Omicsoft OncoLand and QIAGEN Ingenuity...

840 views June 18, 2021

In this 90-minute training, we will discuss how to discover and validate...